Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT
Not yet recruiting · NCT07762755 · Registry updated 2026-08-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CT | Arterial Occlusive Diseases, Dyslipidemias, Lipid Metabolism Disorders, Nutritional and Metabolic Diseases, arteriosclerosis disorder, cardiovascular disorder, coronary artery disorder, heart disorder, hyperlipidemia, hypertriglyceridemia, metabolic disease, myocardial ischemia, vascular disorder | Not yet recruiting | Phase 4 | 2026-08-13 | NCT07762755 |
4 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Beijing Anzhen Hospital | 149 |
| Beijing Chao Yang Hospital | 88 |
| Beijing Municipal Health Commission | 13 |
| China National Center for Cardiovascular Diseases | 115 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Fuwai Hospital | Beijing | China | 18 |